Cytokines in Inflammatory Disease
暂无分享,去创建一个
[1] N. Gay,et al. A leucine‐rich repeat peptide derived from the Drosophila Toll receptor forms extended filaments with a β‐sheet structure , 1991 .
[2] C. Haasper,et al. Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis. , 2010, Technology and health care : official journal of the European Society for Engineering and Medicine.
[3] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[4] A. McKenzie,et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.
[5] Jian-ru Li,et al. Minocycline Protects Against NLRP3 Inflammasome-Induced Inflammation and P53-Associated Apoptosis in Early Brain Injury After Subarachnoid Hemorrhage , 2016, Molecular Neurobiology.
[6] P. Mercier,et al. Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33–LacZ Gene Trap Reporter Strain , 2012, The Journal of Immunology.
[7] R. Ransohoff,et al. The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.
[8] Simon A. Jones,et al. Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production , 2014, Nature Medicine.
[9] C. Janeway. Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.
[10] Changgui Shi,et al. TNF-α suppresses osteogenic differentiation of MSCs by accelerating P2Y2 receptor in estrogen-deficiency induced osteoporosis. , 2018, Bone.
[11] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.
[12] G. van Loo,et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis , 2014, Nature.
[13] M. Jourdan,et al. Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. , 1990, Arthritis and rheumatism.
[14] J. Zhen,et al. AIM2 Mediates Inflammation-Associated Renal Damage in Hepatitis B Virus-Associated Glomerulonephritis by Regulating Caspase-1, IL-1β, and IL-18 , 2014, Mediators of inflammation.
[15] J. Girard,et al. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. , 2014, Current opinion in immunology.
[16] J. Hošek,et al. TNF-α signalling and inflammation: interactions between old acquaintances , 2013, Inflammation Research.
[17] N. Rothwell,et al. AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3 , 2015, Proceedings of the National Academy of Sciences.
[18] E. S. Baekkevold,et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. , 2003, The American journal of pathology.
[19] F. Ciccia,et al. Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)‐1β via the nucleotide‐binding domain and leucine‐rich repeat containing family pyrin 3(NLRP3)‐inflammasome activation: a possible implication for therapeutic decision in , 2015, Clinical and experimental immunology.
[20] S. Akira,et al. TLR signaling , 2006, Cell Death and Differentiation.
[21] D. Solomon,et al. Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] A. Martini,et al. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. , 2007, Arthritis and rheumatism.
[23] N. Gay,et al. A leucine-rich repeat peptide derived from the Drosophila Toll receptor forms extended filaments with a beta-sheet structure. , 1991, FEBS letters.
[24] Yan Wang,et al. Inhibition of P2X4 Suppresses Joint Inflammation and Damage in Collagen-Induced Arthritis , 2014, Inflammation.
[25] L. Groebe,et al. Monocytes/macrophages and/or neutrophils are the target of IL‐10 in the LPS endotoxemia model , 2010, European journal of immunology.
[26] S. Smirnov,et al. Cutting Edge: IL-26 Signals through a Novel Receptor Complex Composed of IL-20 Receptor 1 and IL-10 Receptor 2 1 , 2004, The Journal of Immunology.
[27] W. Chu. Tumor necrosis factor. , 2013, Cancer letters.
[28] M. Gougerot-Pocidalo,et al. Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro. , 1998, European cytokine network.
[29] H. Griffiths,et al. Gingipains from Porphyromonas gingivalis Increase the Chemotactic and Respiratory Burst-Priming Properties of the 77-Amino-Acid Interleukin-8 Variant , 2007, Infection and Immunity.
[30] J. Tschopp,et al. Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1. , 2012, Immunity.
[31] E. Remmers,et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. , 2002, Arthritis and rheumatism.
[32] T. Mak,et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.
[33] B. Castner,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. , 1997, Nature.
[34] B. Mallard,et al. Regulation of bovine intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) on cultured aortic endothelial cells. , 2001, Veterinary immunology and immunopathology.
[35] C. Ryan,et al. TNF-α/IL-10 Ratio Correlates with Burn Severity and May Serve as a Risk Predictor of Increased Susceptibility to Infections , 2016, Front. Public Health.
[36] O. Dittrich‐Breiholz,et al. Multiple control of interleukin‐8 gene expression , 2002, Journal of leukocyte biology.
[37] M. Tada,et al. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study , 2017, Rheumatology International.
[38] M. Seishima,et al. Lack of Interleukin-1&bgr; Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[39] F. Budak,et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[40] J. Lecron,et al. Cytokine signatures in hereditary fever syndromes (HFS). , 2017, Cytokine & growth factor reviews.
[41] Michelle L. Varney,et al. IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis1 , 2003, The Journal of Immunology.
[42] M. Rincón,et al. The two faces of IL-6 on Th1/Th2 differentiation. , 2002, Molecular immunology.
[43] J. Inoue,et al. MOLECULAR ANALYSIS OF CONSTITUTIVE IL-1α GENE EXPRESSION IN HUMAN MELANOMA CELLS: AUTHOCRINE STIMULATION THROUGH NF-κB ACTIVATION BY ENDOGENOUS IL-1α☆ , 1998 .
[44] R. Zhou,et al. DAMP-sensing receptors in sterile inflammation and inflammatory diseases , 2019, Nature Reviews Immunology.
[45] H. Kita,et al. IL-33-activated dendritic cells induce an atypical TH2-type response. , 2009, The Journal of allergy and clinical immunology.
[46] F. Cantatore,et al. Osteoporosis and rheumatic diseases. , 2014, Reumatismo.
[47] K. Garcia,et al. Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex , 2003, Science.
[48] J. Dagvadorj,et al. The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury. , 2013, American journal of respiratory cell and molecular biology.
[49] S. Wang,et al. NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis , 2018, Clinical and experimental immunology.
[50] C. Dinarello,et al. DEMONSTRATION AND CHARACTERIZATION OF TWO DISTINCT HUMAN LEUKOCYTIC PYROGENS , 1974, The Journal of experimental medicine.
[51] S. Cummings,et al. Association of the G‐174C Variant in the Interleukin‐6 Promoter Region With Bone Loss and Fracture Risk in Older Women , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[52] Polly Matzinger,et al. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.
[53] C. Quilici,et al. Imbalanced gp130-Dependent Signaling in Macrophages Alters Macrophage Colony-Stimulating Factor Responsiveness via Regulation of c-fms Expression , 2004, Molecular and Cellular Biology.
[54] R. Lockey,et al. The role of the NLRP3 inflammasome in pulmonary diseases , 2015, Therapeutic advances in respiratory disease.
[55] H. Broxmeyer,et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6 , 1992 .
[56] Krzysztof Safranow,et al. The association of IL-1beta, IL-2, and IL-6 gene polymorphisms with bone mineral density and osteoporosis in postmenopausal women. , 2010, European journal of obstetrics, gynecology, and reproductive biology.
[57] H. Westerblad,et al. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis , 2012, Annals of the rheumatic diseases.
[58] N. Shao,et al. Oxidized low-density lipoprotein induces secretion of interleukin-1β by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation. , 2012, Biochemical and biophysical research communications.
[59] D. Herndon,et al. Predictive Value of IL-8 for Sepsis and Severe Infections After Burn Injury: A Clinical Study , 2015, Shock.
[60] Michael G. Katze,et al. Into the Eye of the Cytokine Storm , 2012, Microbiology and Molecular Reviews.
[61] Chengqi He,et al. TNF-α and IL-6: the link between immune and bone system. , 2020, Current drug targets.
[62] Xiaoling Hu,et al. Expression of RANKL by peripheral neutrophils and its association with bone mineral density in COPD , 2017, Respirology.
[63] T. Taniguchi,et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.
[64] R. Sacco,et al. High-Sensitivity C-Reactive Protein and Interleukin-6–Dominant Inflammation and Ischemic Stroke Risk: The Northern Manhattan Study , 2014, Stroke.
[65] R. Kimberly,et al. Immunobiology of tumor necrosis factor receptor superfamily , 2002, Immunologic research.
[66] Yan Jin,et al. TNF‐α Inhibits FoxO1 by Upregulating miR‐705 to Aggravate Oxidative Damage in Bone Marrow‐Derived Mesenchymal Stem Cells during Osteoporosis , 2016, Stem cells.
[67] Charles Natanson,et al. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. , 2002, American journal of respiratory and critical care medicine.
[68] G. Schett,et al. What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss? , 2019, Front. Immunol..
[69] S. Tural,et al. Association between osteoporosis and polymorphisms of the IL-10 and TGF-beta genes in Turkish postmenopausal women. , 2013, Human immunology.
[70] T. Nakashima,et al. Tumor necrosis factor-α and interleukin-1β increase the Fas-mediated apoptosis of human osteoblasts , 1999 .
[71] Sarah L. Doyle,et al. An eye on the future of inflammasomes and drug development in AMD , 2013, Journal of Molecular Medicine.
[72] K. Özoran,et al. The Effects of Calcitriol Therapy on Serum Interleukin-1, Interleukin-6 and Tumour Necrosis Factor-α Concentrations in Post-menopausal Patients with Osteoporosis , 2004, The Journal of international medical research.
[73] N. Žarković,et al. Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe traumatic brain injury. , 2007, The Tohoku journal of experimental medicine.
[74] H. Chaves,et al. Effects of Atorvastatin on Periodontitis of Rats Subjected to Glucocorticoid-Induced Osteoporosis. , 2016, Journal of periodontology.
[75] N. Ikuta,et al. Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury , 2014, Brain injury.
[76] Ó. Coltell,et al. [Prognostic value of interleukin 6 for death of patients with sepsis]. , 2016, Medicina clinica.
[77] S. Rose-John. Interleukin-6 Family Cytokines. , 2018, Cold Spring Harbor perspectives in biology.
[78] M. Griensven. Cytokines as biomarkers in polytraumatized patients , 2014 .
[79] P. Tak,et al. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. , 2008, Pharmacology & therapeutics.
[80] S. Maier,et al. The danger-associated molecular pattern HMGB1 mediates the neuroinflammatory effects of methamphetamine , 2016, Brain, Behavior, and Immunity.
[81] Yuzhang Wu,et al. NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in han chinese. , 2012, Arthritis and rheumatism.
[82] E. Alnemri,et al. Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.
[83] Xiaopeng Wang,et al. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice , 2019, International immunopharmacology.
[84] Kang Zhang,et al. Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma , 2014, Proceedings of the National Academy of Sciences.
[85] T. Allen,et al. Interleukin 8 and acute lung injury. , 2014, Archives of pathology & laboratory medicine.
[86] Wu Jiang,et al. Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice , 2017, Journal of Neuroinflammation.
[87] C. Fraser,et al. Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age , 2013, Experimental Gerontology.
[88] Chang-Keun Lee,et al. Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study , 2019, Rheumatology International.
[89] Li Xue,et al. TNF-α contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[90] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[91] W. Mu,et al. Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice , 2014, Mediators of inflammation.
[92] R. Ohls,et al. Developmental changes in circulating IL-8/CXCL8 isoforms in neonates. , 2009, Cytokine.
[93] Richard G. Ewers. Into the Eye , 2011 .
[94] H. Gerlach,et al. Early detection of increased tumour necrosis factor alpha (TNFα) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course , 2001, Acta anaesthesiologica Scandinavica.
[95] K. Asadullah,et al. IL‐10 protects monocytes and macrophages from complement‐mediated lysis , 2009, Journal of leukocyte biology.
[96] J. Lederer,et al. Trauma equals danger—damage control by the immune system , 2012, Journal of leukocyte biology.
[97] Tao Wang,et al. [Detection and analysis of serum IL-10 and TGF-β1 in the SLE patients with osteoporosis or osteonecrosis]. , 2018, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.
[98] Francis J. Huber,et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. , 2011, Immunity.
[99] S. Tsunawaki,et al. Expression of NADPH oxidases and enhanced H(2)O(2)-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-alpha. , 2008, International immunopharmacology.
[100] M. Su,et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.
[101] Y. Zhuo,et al. HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma , 2015, Journal of Neuroinflammation.
[102] M. Seibel,et al. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. , 2001, The Journal of clinical endocrinology and metabolism.
[103] G. Criner,et al. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. , 2015, Immunity.
[104] R. Sabat,et al. Biology of interleukin-10. , 2010, Cytokine & growth factor reviews.
[105] N. Warner,et al. Function of Nod‐like receptors in microbial recognition and host defense , 2009, Immunological reviews.
[106] Renu Gupta,et al. Cytokine profiles in osteoporosis suggest a proresorptive bias , 2017, Menopause.
[107] T. Bateman,et al. An NLRP3 Mutation Causes Arthropathy and Osteoporosis in Humanized Mice. , 2016, Cell reports.
[108] Donald W. Miller,et al. Tumor Necrosis Factor-α Induces Cyclooxygenase-2 Expression and Prostaglandin Release in Brain Microvessel Endothelial Cells , 2001 .
[109] T. Hirano,et al. Molecular cloning and expression of an IL-6 signal transducer, gp130 , 1990, Cell.
[110] A Wlodawer,et al. Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. , 1995, Structure.
[111] C. Klein,et al. Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. , 2014, Advances in immunology.
[112] D. Shayakhmetov,et al. Interleukin 1α and the inflammatory process , 2016, Nature Immunology.
[113] S. Nakae,et al. The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses , 2012, Science.
[114] Ran Wang,et al. Association between interleukin-6 gene polymorphisms and bone mineral density: a meta-analysis. , 2013, Genetic testing and molecular biomarkers.
[115] Matthew R. Jones,et al. Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia. , 2006, The Journal of infectious diseases.
[116] D. Rachmilewitz,et al. Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. , 2004, Gastroenterology.
[117] M. Meisner,et al. Markers for sepsis diagnosis: what is useful? , 2006, Critical care clinics.
[118] J. Vincent,et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock , 1995, Journal of Clinical Immunology.
[119] S. Fox,et al. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus , 2007, BMC Cell Biology.
[120] Haichao Wang,et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 , 2007, Journal of leukocyte biology.
[121] J. Reginster,et al. Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. , 1997, Maturitas.
[122] C. Janeway,et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.
[123] T. Mosmann,et al. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.
[124] Daniel T. Fisher,et al. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism , 2006, Nature Immunology.
[125] Yang Zhang,et al. Association of IL-6 G-174C polymorphism with bone mineral density , 2014, Journal of Bone and Mineral Metabolism.
[126] K. Andrews,et al. Interleukin 10 Antioxidant Effect Decreases Leukocytes/Endothelial Interaction Induced by Tumor Necrosis Factor &agr; , 2013, Shock.
[127] H. Bramlett,et al. Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[128] A. Zhang,et al. Clinical relevance of single nucleotide polymorphisms within the entire NLRP3 gene in patients with major blunt trauma , 2011, Critical care.
[129] B. Dalhus,et al. Molecular Requirements for Sorting of the Chemokine Interleukin-8/CXCL8 to Endothelial Weibel-Palade Bodies* , 2009, The Journal of Biological Chemistry.
[130] T. Bringman,et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.
[131] A. Fabre,et al. Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France , 2010, Annals of the rheumatic diseases.
[132] G. Wolf,et al. Interleukin‐6 predicts recurrence and survival among head and neck cancer patients , 2008, Cancer.
[133] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[134] Wen-Tung Wu,et al. Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women , 2010, Annals of Saudi medicine.
[135] D. Lamarre,et al. Interleukin‐10‐induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes , 2008, European journal of immunology.
[136] M. Lehner,et al. Efficient Chemokine-dependent Migration and Primary and Secondary IL-12 Secretion by Human Dendritic Cells Stimulated Through Toll-like Receptors , 2007, Journal of immunotherapy.
[137] B. Mroczko,et al. Diagnostic usefulness of serum interleukin 6 (IL‐6) and C‐reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis , 2010, Journal of clinical laboratory analysis.
[138] K. Asadullah,et al. Expression profiling of IL‐10‐regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL‐10 therapy , 2004, European journal of immunology.
[139] J. Tschopp,et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome , 2011, Cell Death and Disease.
[140] C. Dinarello,et al. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. , 2011, Blood.
[141] U. Walker,et al. Pharmacological treatment options for cryopyrin-associated periodic syndromes , 2017, Expert review of clinical pharmacology.
[142] Raymond P Donnelly,et al. Conformational Changes Mediate Interleukin-10 Receptor 2 (IL-10R2) Binding to IL-10 and Assembly of the Signaling Complex* , 2006, Journal of Biological Chemistry.
[143] R. Locksley,et al. Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. , 2015, Immunity.
[144] Recommendations for the management of autoinflammatory diseases , 2015, Annals of the rheumatic diseases.
[145] Chengqi He,et al. Pro-Inflammatory Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders. , 2017, Current drug targets.
[146] Wei Wu,et al. Identification and functional characterization of a second chain of the interleukin‐10 receptor complex , 1997, The EMBO journal.
[147] K. Winestock,et al. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. , 1995, Journal of immunology.
[148] Dirk E. Smith,et al. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. , 2008, Cytokine.
[149] A. Fischer,et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. , 2002, American journal of human genetics.
[150] H. Lenz,et al. Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models , 2011, International journal of cancer.
[151] U. Maggiore,et al. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[152] L. O’Neill,et al. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. , 2006, Trends in immunology.
[153] S. Brianza,et al. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. , 2008, Bone.
[154] C. Ding,et al. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. , 2008, The Journal of clinical endocrinology and metabolism.
[155] K. Steinberg,et al. Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity. , 2001, American journal of respiratory and critical care medicine.
[156] W. Fraser,et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. , 1990, Clinical science.
[157] J. Collins,et al. Structural conservation of interferon gamma among vertebrates. , 2009, Cytokine & growth factor reviews.
[158] J. Fajar,et al. The association between interleukin 6 −174 G/C gene polymorphism and the risk of osteoporosis: A meta-analysis , 2016, Journal of Taibah University Medical Sciences.
[159] L. Crepaldi,et al. Upregulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10 , 2001 .
[160] S. Yakout,et al. Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis , 2017, Medicine.
[161] L. Ginaldi,et al. Interleukin-33 serum levels in postmenopausal women with osteoporosis , 2019, Scientific Reports.
[162] S. Yakout,et al. Inflammatory and bone turnover markers in relation to PTH and vitamin D status among saudi postmenopausal women with and without osteoporosis. , 2014, International journal of clinical and experimental medicine.
[163] K. Kang,et al. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis , 2016, Cell Death & Disease.
[164] Joseph C. Sun,et al. Cutting Edge: IL-15-Independent NK Cell Response to Mouse Cytomegalovirus Infection1 , 2009, The Journal of Immunology.
[165] T. van der Poll,et al. Ventilator-induced Lung Injury Is Mediated by the NLRP3 Inflammasome , 2012, Anesthesiology.
[166] G. Häcker,et al. Activation of the immune system by bacterial CpG‐DNA , 2002, Immunology.
[167] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[168] T. S. Wilkinson,et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. , 2001, Immunity.
[169] M. Gaestel,et al. Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation , 2010, Journal of Cell Science.
[170] Yuehua Wu,et al. Efficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis , 2015, Medicine.
[171] M. Baggiolini,et al. Interleukin‐8, a chemotactic and inflammatory cytokine , 1992, FEBS letters.
[172] F. Martinon,et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.
[173] F. Schaper,et al. Interleukin-6: Biology, signaling and strategies of blockade. , 2015, Cytokine & growth factor reviews.
[174] J. Dipiro,et al. Interleukin-10 is associated with the development of sepsis in trauma patients. , 1996, The Journal of trauma.
[175] P. Heinrich,et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.
[176] Lijun Xu,et al. Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome , 2018, Calcified Tissue International.
[177] A. Lewin,et al. The NLRP3 Inflammasome and its Role in Age-Related Macular Degeneration. , 2016, Advances in experimental medicine and biology.
[178] T. Nakashima,et al. Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. , 1999, The Journal of laboratory and clinical medicine.
[179] Fei Li,et al. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury , 2018, Neurobiology of Disease.
[180] S. Gupta,et al. IL-18BP is decreased in osteoporotic women: Prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation , 2016, Scientific Reports.
[181] W. Lems,et al. CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts , 2015, PloS one.
[182] I. McInnes,et al. IL‐33 is a chemoattractant for human Th2 cells , 2007, European journal of immunology.
[183] R. Kyle,et al. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. , 1992, Cytokine.
[184] M. Grell. Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. , 1995, Journal of inflammation.
[185] Y. Carmi,et al. The Role of Macrophage-Derived IL-1 in Induction and Maintenance of Angiogenesis1 , 2009, The Journal of Immunology.
[186] Masatoshi Suzuki,et al. Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion , 1998, The Journal of experimental medicine.
[187] M. Willcox,et al. Inflammasomes, the eye and anti-inflammasome therapy , 2017, Eye.
[188] M. Karin,et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.
[189] M. Netea,et al. Bone marrow‐specific caspase‐1/11 deficiency inhibits atherosclerosis development in Ldlr−/− mice , 2015, The FEBS journal.
[190] W. D. Dietrich,et al. Inflammasome proteins as biomarkers of traumatic brain injury , 2018, PLoS ONE.
[191] B. Relja,et al. Nlrp1 inflammasome is downregulated in trauma patients , 2015, Journal of Molecular Medicine.
[192] Y. Liu,et al. Up-Regulation of IL-10R1 Expression Is Required to Render Human Neutrophils Fully Responsive to IL-101 , 2001, The Journal of Immunology.
[193] T. Lawrence. The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.
[194] M. V. von Herrath,et al. Alpha cells, the main source of IL-1β in human pancreas. , 2017, Journal of autoimmunity.
[195] V. Pascual,et al. From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines , 2012, Nature Immunology.
[196] D. Weiner,et al. Interleukin 33: a switch-hitting cytokine. , 2014, Current opinion in immunology.
[197] B. Beutler,et al. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.
[198] J. Bradley,et al. TNF‐mediated inflammatory disease , 2008, The Journal of pathology.
[199] K. Moore,et al. NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.
[200] F. Martinon,et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.
[201] P. Matzinger. Tolerance, danger, and the extended family. , 1994, Annual review of immunology.
[202] L. Joosten,et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. , 2009, Arthritis and rheumatism.
[203] R. Gambari,et al. Mapping the Transcriptional Machinery of the IL-8 Gene in Human Bronchial Epithelial Cells , 2011, The Journal of Immunology.
[204] N. Parameswaran,et al. Loss of interleukin‐10 exacerbates early Type‐1 diabetes‐induced bone loss , 2020, Journal of cellular physiology.
[205] P. Libby,et al. The Present and FutureReview Topic of the WeekInterleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond , 2017 .
[206] Q. Zuo,et al. Ginsenoside Rb1 prevents interleukin-1 beta induced inflammation and apoptosis in human articular chondrocytes , 2013, International Orthopaedics.
[207] C. Dinarello,et al. Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice , 2013, Gut.
[208] K. Dingle,et al. Multivariate Comparison of Cytokine Profiles for Normal- and Low-Bone-Density Subjects , 2019, Diagnostics.
[209] L. Yan,et al. Meta-analysis of association between IL-6 -634C/G polymorphism and osteoporosis. , 2015, Genetics and molecular research : GMR.
[210] Werner Müller,et al. Interleukin‐10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA , 2006, European journal of immunology.
[211] Peter A. Ward,et al. Harmful molecular mechanisms in sepsis , 2008, Nature Reviews Immunology.
[212] R. Flavell,et al. The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer. , 2016, Cytokine & growth factor reviews.
[213] R. Thompson,et al. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. , 1994, The Journal of clinical investigation.
[214] Jiwang Zhang,et al. TNF-α/Fas-RIP-1-induced cell death signaling separates murine hematopoietic stem cells/progenitors into 2 distinct populations. , 2011, Blood.
[215] J. Lederer,et al. A Protective Role for Inflammasome Activation Following Injury , 2012, Shock.
[216] R. Kolodner,et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome , 2001, Nature Genetics.
[217] A. Mantovani,et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.
[218] P. Gourdy,et al. The pro‐Th2 cytokine IL‐33 directly interacts with invariant NKT and NK cells to induce IFN‐γ production , 2009, European journal of immunology.
[219] Ke Chen,et al. NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation. , 2017, Biochemical and biophysical research communications.
[220] Tack-Joong Kim,et al. Triglyceride-induced macrophage cell death is triggered by caspase-1. , 2013, Biological & pharmaceutical bulletin.
[221] S. Akira,et al. Pattern Recognition Receptors and Inflammation , 2010, Cell.
[222] L. Joosten,et al. Inflammasome-independent Role of Apoptosis-associated Speck-like Protein Containing a CARD (ASC) in T Cell Priming Is Critical for Collagen-induced Arthritis* , 2010, The Journal of Biological Chemistry.
[223] J. Scheller,et al. Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN. , 2015, Journal of the American Society of Nephrology : JASN.
[224] R. Ramjeesingh,et al. Interleukin‐8 secreted by endothelial cells induces Chemotaxis of melanoma cells through the chemokine receptor CXCR1 , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[225] L. Moldawer,et al. Is there value in plasma cytokine measurements in patients with severe trauma and sepsis? , 2013, Methods.
[226] Nicole Nelson,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.
[227] M. Gubina,et al. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[228] Yoshiro Kobayashi. The role of chemokines in neutrophil biology. , 2008, Frontiers in bioscience : a journal and virtual library.
[229] L. Joosten,et al. Inflammasome-independent regulation of IL-1-family cytokines. , 2015, Annual review of immunology.
[230] C. Fielding,et al. IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[231] S. Rose-John,et al. Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[232] B. Koller,et al. NLRP1-Dependent Pyroptosis Leads to Acute Lung Injury and Morbidity in Mice , 2012, The Journal of Immunology.
[233] E. Hoppenreijs,et al. A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis) , 2016, Annals of the rheumatic diseases.
[234] P. V. van Eeden,et al. Sustained Elevation of Resistin, NGAL and IL-8 Are Associated with Severe Sepsis/Septic Shock in the Emergency Department , 2014, PloS one.
[235] C. Dinarello,et al. Treating inflammation by blocking interleukin-1 in humans. , 2013, Seminars in immunology.
[236] J. Hollyfield,et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components , 2012, Nature Medicine.
[237] K. Nas,et al. Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy , 2002, Rheumatology International.
[238] J. Cañete,et al. The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis , 2016, Expert opinion on drug safety.
[239] C. Hunter,et al. IL-6 as a keystone cytokine in health and disease , 2015, Nature Immunology.
[240] D. Boumpas,et al. Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis , 2015, Arthritis Research & Therapy.
[241] C. Shao,et al. Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression , 2010, The Journal of Immunology.
[242] S. Tsao,et al. Enhanced IL-6/IL-6R Signaling Promotes Growth and Malignant Properties in EBV-Infected Premalignant and Cancerous Nasopharyngeal Epithelial Cells , 2013, PloS one.
[243] A. Aygun,et al. Serum IL-1β, IL-6, IL-8, and TNF-α Levels in Early Diagnosis and Management of Neonatal Sepsis , 2008, Mediators of inflammation.
[244] H. Olivecrona,et al. Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes , 2016, Rheumatology.
[245] J. Inoue,et al. Molecular analysis of constitutive IL-1alpha gene expression in human melanoma cells: autocrine stimulation through NF-kappaB activation by endogenous IL-1alpha. , 1998, Cytokine.
[246] Yangang Wang,et al. Resveratrol pretreatment attenuates traumatic brain injury in rats by suppressing NLRP3 inflammasome activation via SIRT1. , 2017, Molecular medicine reports.
[247] Delphine A. Lacorre,et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.
[248] N. Hempel,et al. Redox-control of the alarmin, Interleukin-1α☆ , 2013, Redox biology.
[249] K. Kang,et al. Auranofin Inhibits RANKL-Induced Osteoclastogenesis by Suppressing Inhibitors of κB Kinase and Inflammasome-Mediated Interleukin-1β Secretion , 2019, Oxidative medicine and cellular longevity.
[250] J. P. de Rivero Vaccari,et al. Traumatic Brain Injury-Induced Acute Lung Injury: Evidence for Activation and Inhibition of a Neural-Respiratory-Inflammasome Axis. , 2018, Journal of neurotrauma.
[251] T. Ma,et al. IL-1β Causes an Increase in Intestinal Epithelial Tight Junction Permeability1 , 2007, The Journal of Immunology.
[252] C. Dinarello,et al. The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines , 2013, Front. Immunol..
[253] A. Yoshimura,et al. IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. , 2013, The Journal of clinical investigation.
[254] P. Lacativa,et al. Osteoporosis and inflammation. , 2010, Arquivos brasileiros de endocrinologia e metabologia.
[255] U. Steckholzer,et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. , 1997, The Journal of trauma.
[256] F. Horn,et al. Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells. , 2004, The Biochemical journal.
[257] M. Saraya,et al. Evaluation of leptin, interleukin-1 beta and tumor necrosis factor alpha in serum of malaria patients as prognostic markers of treatment outcome. , 2014, Asian Pacific journal of tropical biomedicine.
[258] R. Pierce,et al. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. , 2013, The Journal of clinical investigation.
[259] J. Piette,et al. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. , 2005, Arthritis and rheumatism.
[260] G. Dubyak,et al. Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages1 , 2007, The Journal of Immunology.
[261] A. De La Hera,et al. Mortality in Patients With Septic Shock Correlates With Anti-Inflammatory But not Proinflammatory Immunomodulatory Molecules , 2011, Journal of intensive care medicine.
[262] Min Wu,et al. 11β-Hydroxysteroid dehydrogenase 1 inhibition attenuates collagen-induced arthritis. , 2013, International Immunopharmacology.
[263] O. Reikerås,et al. Activation of Markers of Inflammation, Coagulation and Fibrinolysis in Musculoskeletal Trauma , 2014, PloS one.
[264] G. Fernández,et al. Interleukin-10 controls human peripheral PMN activation triggered by lipopolysaccharide. , 2013, Cytokine.
[265] C. Dinarello,et al. Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.
[266] D. Miller,et al. Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. , 2001, The Journal of pharmacology and experimental therapeutics.
[267] K. Safranow,et al. TNF-α and IL10 gene polymorphisms in women with postmenopausal osteoporosis. , 2016, European journal of obstetrics, gynecology, and reproductive biology.
[268] T. van der Poll,et al. Severe sepsis and septic shock. , 2013, The New England journal of medicine.
[269] Richard T. Lee,et al. Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells* , 2012, The Journal of Biological Chemistry.